Filing Details
- Accession Number:
- 0001179110-20-003999
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-19 19:28:41
- Reporting Period:
- 2020-03-19
- Accepted Time:
- 2020-03-19 19:28:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc. | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291219 | J Kenneth Kelley | C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-19 | 17,543 | $14.19 | 242,467 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-19 | 17,543 | $14.25 | 260,010 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-19 | 17,543 | $14.24 | 277,553 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $14.11 to $14.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $14.23 to $14.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $14.15 to $14.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Billionaire Hedge Funds
